JP2024545064A5 - - Google Patents

Info

Publication number
JP2024545064A5
JP2024545064A5 JP2024533231A JP2024533231A JP2024545064A5 JP 2024545064 A5 JP2024545064 A5 JP 2024545064A5 JP 2024533231 A JP2024533231 A JP 2024533231A JP 2024533231 A JP2024533231 A JP 2024533231A JP 2024545064 A5 JP2024545064 A5 JP 2024545064A5
Authority
JP
Japan
Prior art keywords
strain
health
bacillus clausii
composition
microbial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545064A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081161 external-priority patent/WO2023108055A1/en
Publication of JP2024545064A publication Critical patent/JP2024545064A/ja
Publication of JP2024545064A5 publication Critical patent/JP2024545064A5/ja
Pending legal-status Critical Current

Links

JP2024533231A 2021-12-08 2022-12-08 バチルス・クラウシイ(bacillus clausii)株、その組成物及び使用の方法 Pending JP2024545064A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE20210209 2021-12-08
IE2021/0209 2021-12-08
PCT/US2022/081161 WO2023108055A1 (en) 2021-12-08 2022-12-08 Bacillus clausii strain, compositions thereof, and methods of use

Publications (2)

Publication Number Publication Date
JP2024545064A JP2024545064A (ja) 2024-12-05
JP2024545064A5 true JP2024545064A5 (https=) 2025-12-15

Family

ID=85076311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533231A Pending JP2024545064A (ja) 2021-12-08 2022-12-08 バチルス・クラウシイ(bacillus clausii)株、その組成物及び使用の方法

Country Status (10)

Country Link
US (1) US20250170188A1 (https=)
EP (1) EP4444861A1 (https=)
JP (1) JP2024545064A (https=)
KR (1) KR20240141161A (https=)
CN (1) CN119563016A (https=)
AU (1) AU2022407518A1 (https=)
CA (1) CA3239840A1 (https=)
MX (1) MX2024006846A (https=)
WO (1) WO2023108055A1 (https=)
ZA (1) ZA202404358B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118511996A (zh) * 2024-04-25 2024-08-20 晏龙国科(山东)微生物科技有限公司 一种含益生菌的抗衰老组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11160838B2 (en) * 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions

Similar Documents

Publication Publication Date Title
JP2024546089A5 (https=)
Stavropoulou et al. Probiotics in medicine: a long debate
JP6701276B2 (ja) 細菌株を含む組成物
CN102905712B (zh) 用于治疗肠炎的益生菌组合物
Wang et al. Influence of Lactobacillus fermentum I5007 on the intestinal and systemic immune responses of healthy and E. coli challenged piglets
RU2004130876A (ru) Штаммы lactobacillus
AU2019379234B2 (en) Strains, composition and method of use
EP4009995B1 (en) Probiotic mixture
JP2024535901A (ja) 新規プロバイオティクスおよびその用途
JP2024546089A (ja) バチルス・メガテリウム(Bacillus megaterium)株、その組成物及び使用の方法
JP2024539315A (ja) 腸内マイクロバイオーム調節のためのプロバイオティクス組成物
Reid et al. The role of Lactobacilli in preventing urogenital and intestinal infections
CN108379297B (zh) 益生菌及其外膜囊泡在制备防治骨质疏松症药物中的应用
JP3017493B1 (ja) 自己免疫疾患予防組成物
JP2024545064A5 (https=)
JP2024544211A5 (https=)
Nagaraj et al. Probiotics and oral health
JP5209294B2 (ja) インターロイキン12産生促進剤
JP2000060541A (ja) ビフィズス菌増殖促進物質と整腸物質とビフィズス菌製剤
CA3078305A1 (en) A pharmaceutical composition comprising a probiotic and a prebiotic to prevent acquisition of or treat drug resistant infections
JP2024545064A (ja) バチルス・クラウシイ(bacillus clausii)株、その組成物及び使用の方法
LeBlanc et al. Mechanisms involved in the anti-inflammatory properties of native and genetically engineered lactic acid bacteria
HK40128671A (zh) 鼠李糖乳酪杆菌菌株及其免疫增强用途
JP2023091935A (ja) ラクトコッカス属乳酸菌を含むストレス反応軽減剤
Kroeker et al. Treatment of Ulcerative Colitis